当前位置:首页 - 行情中心 - 兴齐眼药(300573) - 财务分析 - 现金流量表

兴齐眼药

(300573)

  

流通市值:102.24亿  总市值:133.41亿
流通股本:2.72亿   总股本:3.55亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,389,919,559.86676,557,246.862,439,399,907.521,833,095,200.26
  收到的税费返还--320,638.74-
  收到其他与经营活动有关的现金12,498,026.472,510,197.6417,867,206.2115,040,435.52
  经营活动现金流入小计1,402,417,586.33679,067,444.52,457,587,752.471,848,135,635.78
  购买商品、接受劳务支付的现金93,610,760.8234,913,421.24186,411,330.45140,630,297.06
  支付给职工以及为职工支付的现金339,049,822.4173,870,649.16620,224,927.67467,601,331.97
  支付的各项税费212,235,304.2497,411,482.96309,204,408.82241,149,021.54
  支付其他与经营活动有关的现金364,075,085.37164,424,491.7588,358,299.85424,234,800.91
  经营活动现金流出小计1,008,970,972.83470,620,045.061,704,198,966.791,273,615,451.48
  经营活动产生的现金流量净额393,446,613.5208,447,399.44753,388,785.68574,520,184.3
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额22,553.49-50,00044,247.79
  处置子公司及其他营业单位收到的现金净额-643,500.98---
  收到的其他与投资活动有关的现金--4,631,632.36-
  投资活动现金流入的平衡项目0-00
  投资活动现金流入小计-620,947.49-4,681,632.3644,247.79
  购建固定资产、无形资产和其他长期资产支付的现金61,599,343.626,637,575.12270,526,699.17131,875,957.56
  支付其他与投资活动有关的现金400,000400,0003,890,831.82-
  投资活动现金流出小计61,999,343.627,037,575.12274,417,530.99131,875,957.56
  投资活动产生的现金流量净额-62,620,291.09-27,037,575.12-269,735,898.63-131,831,709.77
三、筹资活动产生的现金流量:
  吸收投资收到的现金10,500,000-19,223,553.78-
  其中:子公司吸收少数股东投资收到的现金10,500,000---
  取得借款收到的现金50,000,000-181,000,000181,000,000
  收到其他与筹资活动有关的现金--37,298,177.7128,763,009.81
  筹资活动现金流入平衡项目0-00
  筹资活动现金流入小计60,500,000-237,521,731.49209,763,009.81
  偿还债务支付的现金70,000,000-311,000,000261,000,000
  分配股利、利润或偿付利息支付的现金247,007,154.77417,499.99351,083,200.15350,904,435.8
  支付其他与筹资活动有关的现金3,487,649.71,582,136.2733,829,630.829,508,575.26
  筹资活动现金流出小计320,494,804.471,999,636.26695,912,830.95641,413,011.06
  筹资活动产生的现金流量净额-259,994,804.47-1,999,636.26-458,391,099.46-431,650,001.25
四、汇率变动对现金及现金等价物的影响1,702,119.61907,818.63-1,669,055.28-1,647,447.59
五、现金及现金等价物净增加额72,533,637.55180,318,006.6923,592,732.319,391,025.69
  加:期初现金及现金等价物余额386,429,915.27386,429,915.27362,837,182.96362,837,182.96
  期末现金及现金等价物余额458,963,552.82566,747,921.96386,429,915.27372,228,208.65
补充资料:
  净利润430,404,293.36-695,855,596.25-
  资产减值准备1,797,496.46-15,176,291.68-
  固定资产和投资性房地产折旧51,681,942.61-91,890,630.49-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧51,681,942.61-91,890,630.49-
  无形资产摊销9,645,411.02-11,568,709.56-
  长期待摊费用摊销1,250,500.07-2,593,093.55-
  处置固定资产、无形资产和其他长期资产的损失-7,973.32--52,536.38-
  固定资产报废损失39,007.1-495,132.67-
  财务费用-1,025,135.05-6,104,842.08-
  投资损失-5,126,142.18---
  递延所得税-2,008,185.37-4,368,487.14-
  其中:递延所得税资产减少-2,008,185.37-4,368,487.14-
  存货的减少-18,502,657.27--47,601,868.52-
  经营性应收项目的减少-79,045,461.18--174,849,913.41-
  经营性应付项目的增加-2,289,757.52-129,834,838.88-
  其他2,079,041.64-6,598,501.41-
  现金的期末余额458,963,552.82-386,429,915.27-
  减:现金的期初余额386,429,915.27-362,837,182.96-
  现金及现金等价物的净增加额72,533,637.55-23,592,732.31-
公告日期2026-08-282026-04-282026-04-222025-10-29
审计意见(境内)标准无保留意见
TOP↑